• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Traditional Chinese medicine: cardiovascular drug development through a holistic framework.

作者信息

Packer Milton

机构信息

Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 North Hall Street, Dallas, TX, USA.

Imperial College, London, UK.

出版信息

Eur Heart J. 2024 Oct 21;45(40):4315-4317. doi: 10.1093/eurheartj/ehae625.

DOI:10.1093/eurheartj/ehae625
PMID:39288272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11491152/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9089/11491152/306b69af0a1b/ehae625_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9089/11491152/306b69af0a1b/ehae625_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9089/11491152/306b69af0a1b/ehae625_ga.jpg

相似文献

1
Traditional Chinese medicine: cardiovascular drug development through a holistic framework.传统中医：通过整体框架进行心血管药物研发。
Eur Heart J. 2024 Oct 21;45(40):4315-4317. doi: 10.1093/eurheartj/ehae625.
2
[Intrinsic "self-consistent" phenomenon based on holistic view of traditional Chinese medicine].基于中医整体观的内在“自洽”现象
Zhongguo Zhong Yao Za Zhi. 2023 Dec;48(23):6526-6532. doi: 10.19540/j.cnki.cjcmm.20230904.302.
3
A review of using Traditional Chinese Medicine in the management of glaucoma and cataract.中药治疗青光眼和白内障的研究综述。
Clin Exp Optom. 2024 Mar;107(2):156-170. doi: 10.1080/08164622.2023.2246480. Epub 2023 Oct 25.
4
Study on the Prognosis Effect of Traditional Chinese Medicine Treatment in DR Patients Based on the Perspective of Network Pharmacology.基于网络药理学视角的 DR 患者中医药治疗预后效果研究。
Contrast Media Mol Imaging. 2022 Jul 19;2022:3528732. doi: 10.1155/2022/3528732. eCollection 2022.
5
CDCS-TCM: A framework based on complex network theory to analyze the causality and dynamic correlation of substances in the metabolic process of traditional Chinese medicine.中医成分动态关联分析框架：基于复杂网络理论的中医代谢过程中物质因果关系和动态相关性分析框架
J Ethnopharmacol. 2024 Jun 28;328:118100. doi: 10.1016/j.jep.2024.118100. Epub 2024 Mar 26.
6
Nurses and Holistic Modalities: The History of Chinese Medicine and Acupuncture.护士与整体疗法：中医与针灸的历史
Holist Nurs Pract. 2019 Mar/Apr;33(2):90-94. doi: 10.1097/HNP.0000000000000312.
7
Recent highlights of metabolomics for traditional Chinese medicine.中药代谢组学的近期研究亮点。
Pharmazie. 2012 Aug;67(8):667-75.
8
[Treatment of COVID-19 guided by holistic view of traditional Chinese medicine--therapy aimed at both viral and host].中医整体观指导下的新型冠状病毒肺炎治疗——针对病毒与宿主的疗法
Zhongguo Zhong Yao Za Zhi. 2020 Apr;45(7):1521-1525. doi: 10.19540/j.cnki.cjcmm.20200304.501.
9
The Holistic Philosophy of Traditional Chinese Medicine and Conflicts With Modern Medicine.传统中医的整体哲学观与现代医学的冲突。
Holist Nurs Pract. 2023;37(3):153-160. doi: 10.1097/HNP.0000000000000508. Epub 2022 Apr 5.
10
[Quality by design approaches for pharmaceutical development and manufacturing of Chinese medicine].[中药研发与生产的质量源于设计方法]
Zhongguo Zhong Yao Za Zhi. 2017 Mar;42(6):1015-1024. doi: 10.19540/j.cnki.cjcmm.20170222.019.

本文引用的文献

1
Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial.参松养心预防持续性心房颤动导管消融后房性快速心律失常的疗效观察（SS-AFRF 试验）。
Eur Heart J. 2024 Oct 21;45(40):4305-4314. doi: 10.1093/eurheartj/ehae532.
2
Efficacy and safety of Shen Gui capsules for chronic heart failure: a systematic review and meta-analysis.参桂胶囊治疗慢性心力衰竭的疗效与安全性：一项系统评价与Meta分析
Front Pharmacol. 2024 Apr 10;15:1347828. doi: 10.3389/fphar.2024.1347828. eCollection 2024.
3
Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
芪苈强心：心力衰竭的多方位整体治疗，还是心脏保护机制的药理学探索？
Eur J Heart Fail. 2023 Dec;25(12):2130-2143. doi: 10.1002/ejhf.3068. Epub 2023 Nov 14.
4
Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.中药复方（通心络）对急性心肌梗死患者临床结局的影响：CTS-AMI 随机临床试验。
JAMA. 2023 Oct 24;330(16):1534-1545. doi: 10.1001/jama.2023.19524.
5
Shensong Yangxin Capsule Reduces the Susceptibility of Arrhythmia in db/db Mice via Inhibiting the Inflammatory Response Induced by Endothelium Dysfunction.参松养心胶囊通过抑制内皮功能障碍引起的炎症反应降低 db/db 小鼠心律失常易感性。
Drug Des Devel Ther. 2023 Feb 5;17:313-330. doi: 10.2147/DDDT.S392328. eCollection 2023.
6
SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism.SGLT2 抑制剂：在心脏营养物质转运和代谢的保护性重编程中的作用。
Nat Rev Cardiol. 2023 Jul;20(7):443-462. doi: 10.1038/s41569-022-00824-4. Epub 2023 Jan 6.
7
Characteristic analysis of clinical trials for new traditional Chinese medicines in mainland China from 2013 to 2021.2013年至2021年中国大陆中药新药临床试验特征分析
Front Med (Lausanne). 2022 Oct 18;9:1008683. doi: 10.3389/fmed.2022.1008683. eCollection 2022.
8
Investigating the efficiency and tolerability of traditional Chinese formulas combined with antiarrhythmic agents for paroxysmal atrial fibrillation: A systematic review and Bayesian network meta-analysis.探讨中药方剂联合抗心律失常药物治疗阵发性心房颤动的有效性和耐受性：一项系统评价和贝叶斯网络Meta分析。
Phytomedicine. 2022 Jan;94:153832. doi: 10.1016/j.phymed.2021.153832. Epub 2021 Oct 29.
9
Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study.通心络胶囊干预颈动脉斑块的随机、双盲、平行对照、多中心临床研究（CAPITAL）
Sci Rep. 2019 Mar 14;9(1):4545. doi: 10.1038/s41598-019-41118-z.
10
Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.参松养心胶囊通过抑制心肌梗死后心力衰竭大鼠的心房纤维化来降低房颤易感性。
Drug Des Devel Ther. 2018 Oct 10;12:3407-3418. doi: 10.2147/DDDT.S182834. eCollection 2018.